Skip to main content

Population Pharmacokinetics to Support Intravenous and Enteral Methadone Dosing in Children.

Publication ,  Journal Article
Watt, KM; Thompson, EJ; Lam, L; Zimmerman, K; Hornik, CP; Atz, AM; Fernandez, A; Hupp, SR; Bhatt-Mehta, V; Benjamin, DK; Anand, R; Gonzalez, D ...
Published in: J Clin Pharmacol
January 2026

Methadone is used in hospitalized children to treat pain and iatrogenic opiate withdrawal. Optimal pediatric dosing for both enteral and intravenous methadone is unknown. We conducted two prospective, multi-center, open-label studies to characterize the pharmacokinetics of methadone in the pediatric population. These studies were conducted at a total of 23 US children's hospitals. Ninety-nine children with a median (range) age of 2.3 (0-19.0) years and weight of 13.0 (0.72-159) kg were prescribed methadone per standard of care for treatment of pain or iatrogenic opiate withdrawal. Ninety-nine children received median (range) methadone doses of 0.11 (0.01-0.39) mg/kg intravenously and 0.10 (0.01-0.61) mg/kg enterally. Ten participants received only intravenous doses; 78 received only enteral doses; and 11 received intravenous and enteral doses. We analyzed 263 pharmacokinetic samples with a median (range) methadone plasma concentration of 42.2 (0.9-729.2) ng/mL. A one-compartment population pharmacokinetic model described the methadone data well. Median (range) empiric Bayesian estimates of clearance, volume of distribution, and half-life were 0.17 (0.009-1.50) L/h/kg, 4.99 (0.97-20.6) L/kg, and 20.5 (3.0-86.2) h, respectively. Dosing simulations showed that doses of 0.1 mg/kg every 8 h (intravenous) and 0.2 mg/kg every 8 h (enteral) achieved exposures associated with pain control and reduction in withdrawal symptoms. Based on observed exposures and model simulations, we recommend a starting dose of 0.1 mg/kg intravenous or 0.2 mg/kg enterally (max 10 mg) every 8 h. Because of wide interindividual variability, this dose should be titrated to effect.

Duke Scholars

Published In

J Clin Pharmacol

DOI

EISSN

1552-4604

Publication Date

January 2026

Volume

66

Issue

1

Start / End Page

e70143

Location

England

Related Subject Headings

  • Young Adult
  • Prospective Studies
  • Pharmacology & Pharmacy
  • Models, Biological
  • Methadone
  • Male
  • Infant
  • Humans
  • Half-Life
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Watt, K. M., Thompson, E. J., Lam, L., Zimmerman, K., Hornik, C. P., Atz, A. M., … Best Pharmaceuticals for Children Act — Pediatric Trials Network Steering Committee. (2026). Population Pharmacokinetics to Support Intravenous and Enteral Methadone Dosing in Children. J Clin Pharmacol, 66(1), e70143. https://doi.org/10.1002/jcph.70143
Watt, Kevin M., Elizabeth J. Thompson, Lisa Lam, Kanecia Zimmerman, Christoph P. Hornik, Andrew M. Atz, Allison Fernandez, et al. “Population Pharmacokinetics to Support Intravenous and Enteral Methadone Dosing in Children.J Clin Pharmacol 66, no. 1 (January 2026): e70143. https://doi.org/10.1002/jcph.70143.
Watt KM, Thompson EJ, Lam L, Zimmerman K, Hornik CP, Atz AM, et al. Population Pharmacokinetics to Support Intravenous and Enteral Methadone Dosing in Children. J Clin Pharmacol. 2026 Jan;66(1):e70143.
Watt, Kevin M., et al. “Population Pharmacokinetics to Support Intravenous and Enteral Methadone Dosing in Children.J Clin Pharmacol, vol. 66, no. 1, Jan. 2026, p. e70143. Pubmed, doi:10.1002/jcph.70143.
Watt KM, Thompson EJ, Lam L, Zimmerman K, Hornik CP, Atz AM, Fernandez A, Hupp SR, Bhatt-Mehta V, Benjamin DK, Anand R, Cohen-Wolkowiez M, Gonzalez D, Smith PB, Capparelli EV, Best Pharmaceuticals for Children Act — Pediatric Trials Network Steering Committee. Population Pharmacokinetics to Support Intravenous and Enteral Methadone Dosing in Children. J Clin Pharmacol. 2026 Jan;66(1):e70143.

Published In

J Clin Pharmacol

DOI

EISSN

1552-4604

Publication Date

January 2026

Volume

66

Issue

1

Start / End Page

e70143

Location

England

Related Subject Headings

  • Young Adult
  • Prospective Studies
  • Pharmacology & Pharmacy
  • Models, Biological
  • Methadone
  • Male
  • Infant
  • Humans
  • Half-Life
  • Female